Klaus Eyer
Has grant
Associate Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Klaus Eyer is an Associate Professor at Aarhus University in Denmark. His research focuses on single-cell analysis, with recent articles exploring topics such as antibody secretion, cytokine release dynamics, and the functional heterogeneity of immune cells. He is particularly interested in the development of innovative microfluidic platforms for studying immune responses and the quantitative assessment of immunization effects.
Recent Grants
Grant: Close
New bridges across the translational gap
Open Date: 2019-09-01
Close Date: 2021-08-01
Grant: Close
High-throughput single-cell phenotypic analysis of functional antibody repertoires
Open Date: 2019-02-01
Close Date: 2024-01-31
Grant: Close
Functional high-throughput single-cell analysis towards the rational development of new vaccines
Open Date: 2016-09-01
Close Date: 2021-09-01
Grant: Close
Time resolved ultrahigh resolution phenotypic mapping of antibody producing cells
Open Date: 2016-09-01
Close Date: 2018-02-28
Grant: Close
Detection of circulating tumor cells in patients
Open Date: 2016-05-01
Close Date:
Positions (2)
Klaus Eyer
Aarhus University
1 year ago
The MSCA-DN TRANSCEND network, coordinated by Associate Professor Klaus Eyer at Aarhus University, is recruiting two doctoral students for cutting-edge research in multiple sclerosis (MS). The first PhD position focuses on deep-phenotyping of anti-lipid autoantibodies in MS at the single-antibody level, with collaborative research exchanges in Milan under the supervision of Dr. Daniela Latorre, an expert in autoreactive T cells. The second PhD position centers on functional multiomic profiling of circulating immune cells in MS, including a research stay at Amsterdam UMC with Dr. Gijs Kooij, a specialist in MS and inflammation. TRANSCEND is a transdisciplinary network aiming to revolutionize translational research for complex conditions, integrating science, philosophy, and patient-centered care. Applicants should have a relevant master's degree and a strong background in immunology, molecular biology, or neuroscience. Both positions are fully funded and offer international research opportunities. Applications must be submitted via the provided links by October 30, 2024. For more information, visit the TRANSCEND network page and the Euraxess platform.
1 year ago
Klaus Eyer
Aarhus University
1 month ago
Open fully financed PhD position at Aarhus University , Department of Biomedicine, in a project on single-cell analysis of autoreactive antibody repertoires . The research will investigate the diversity, specificity, and function of autoreactive antibodies at single-cell resolution. The project combines immunology , antibody biology , single-cell technologies , and data science , with a strong translational angle and collaboration with clinical partners. This is a good fit for candidates interested in Biology , Medical Science , and related biomedical methods. The position is supported by funding from the Independent Research Fund Denmark . Deadline: 25 September 2026. Preferred start: 1 December 2026 (negotiable). Applications must be submitted through the official application portal; the poster explicitly says no applications by email . The poster also invites interested applicants to reach out with questions.
1 month ago
Articles (10)
Year:
2023
Year:
2023
Increasing evidence suggests that natural killer (NK) cells are composed of distinct functional subsets. This multifunctional role has made them an attractive choice for anticancer immunotherapy. A functional NK cell repertoire is generated through cellular education, resulting in a heterogeneous NK cell population with distinct capabilities responding to different stimuli. The application of a high‐throughput droplet‐based microfluidic platform allows monitoring of NK cell‐target cell interactions at the single‐cell level and in real‐time. A variable response of single NK cells toward different target cells is observed, and a distinct population of NK cells (serial killers) capable of inducing multiple target lysis is identified. By assessing the cytotoxic dynamics, it is shown that single umbilical cord blood‐derived CD34+ hematopoietic progenitor (HPC)‐NK cells display superior antitumor cytotoxicity. With an integrated analysis of cytotoxicity and cytokine secretion, it is shown that target cell interactions augment cytotoxic as well as secretory behavior of NK cells. By providing an integrated assessment of NK cell functions by microfluidics, this study paves the way to further functionally characterize NK cells ultimately aimed to improve cancer immunotherapy.
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (4)
Jean Baudry
-
Paul de Jonge
Senior Scientist & Deputy Head Cell Therapy Facility
Radboudumc
Mark van Turnhout
Eindhoven University of Technology
Jurjen Tel
-
Make your next move.
Prepare your application
Review drafts before you send them.